Administrative Core
行政核心
基本信息
- 批准号:10705227
- 负责人:
- 金额:$ 34.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-24 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcademyAccelerationAccountingAddressAdministratorBrainBrain NeoplasmsCancer EtiologyCancer PatientClinical SciencesClinical TrialsCollaborationsCommunicationComplexDataData CommonsData ProvenanceDepartment chairDevelopmentDoctor of PhilosophyEnsureEvaluationExpenditureFundingGoalsGrantHomeHuman ResourcesInfrastructureInstitutionInternationalLeadershipMalignant NeoplasmsMalignant neoplasm of brainMedicineMolecularMonitorOccupational activity of managing financesOffice of Administrative ManagementPatient-Focused OutcomesPatientsPoliciesPreparationPrimary Brain NeoplasmsProceduresProcessProductivityPublicationsRecommendationRegulationRegulatory AffairsReportingReproduction sporesResearchResearch DesignResearch PersonnelResearch Project GrantsResearch SubjectsResource SharingResourcesScheduleSpecimenTrainingTranslational ResearchUnited States National Institutes of HealthUniversitiesVertebratesVisitcareerchildhood cancer mortalityclinical developmentconflict resolutiondata integritydata managementdata sharingexperiencehuman subjectimprovedimproved outcomemedical schoolsmeetingsneuro-oncologyneurosurgeryoperationpatient populationprofessorprogramsquality assurancesuccesstherapeutic developmentyoung adult
项目摘要
ABSTRACT – Administrative Core
The Administrative Core provides comprehensive administrative and scientific management for all components
of the Duke Brain SPORE, including research Projects 1-3, three Shared Resource Cores, and both
Developmental Research and Career Enhancement Programs. Programmatic oversight will be provided by the
Administrative Core Co-Leads, as well as an Executive Committee consisting of Project and Core Leads and
Internal and External Advisory Boards. The functions of the Administrative Core will be carried out through the
following Specific Aims: 1) Provide administrative management and oversight; 2) Provide financial
management and ensure compliance with fiscal and research policies; 3) Provide oversight of all data
operations; 4) To promote integration within the SPORE and the Institution; 5) Maintain and support access to
an adequate cancer patient population; and 6) Provide scientific management and evaluate research
progress. Through these Aims, the Core ensures the full range of support required to provide administrative
management; promote integration, communication, and collaboration; ensure fiscal and regulatory compliance;
and oversee data operations, scientific rigor, and research progress. By serving these functions, the
Administrative Core allows SPORE investigators to focus on conducting and advancing the translational
science supported by the SPORE.
摘要 - 行政核心
行政核心为所有组件提供全面的行政和科学管理
杜克大脑孢子(包括研究项目1-3),三个共享资源核心以及两者都
发展研究和职业增强计划。编程监督将由
行政核心联合领导者以及由项目和核心潜在客户组成的执行委员会
内部和外部咨询委员会。行政核心的功能将通过
以下特定目的:1)提供行政管理和监督; 2)提供财务
管理并确保遵守财政和研究政策; 3)提供所有数据的监督
运营; 4)促进在孢子和机构内部的融合; 5)维护和支持访问
足够的癌症患者人群; 6)提供科学管理并评估研究
进步。通过这些目标,核心确保提供行政的全部支持范围
管理;促进集成,沟通和协作;确保财政和监管合规;
并监督数据操作,科学严谨和研究进度。通过服务这些功能,
行政核心使孢子调查人员能够专注于进行和推进翻译
科学在孢子的支持下。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David M. Ashley其他文献
Phase II study of carboplatin (CBDCA) in progressive low-grade gliomas.
卡铂 (CBDCA) 在进行性低级别胶质瘤中的 II 期研究。
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:4.1
- 作者:
Albert Moghrabi;Henry S Friedman;David M. Ashley;K. Bottom;T. Kerby;Elizabeth A. Stewart;Carol S. Bruggers;James M. Provenzale;Martin A. Champagne;Linda Hershon;M. Watral;Janis Ryan;Karima Rasheed;Shelley Lovell;David N. Korones;Herbert E. Fuchs;Timothy M George;R. McLendon;A. Friedman;Edward G. Buckley;D. Longee - 通讯作者:
D. Longee
The evolution of the histology in pleomorphic xanthoastrocytomas in children: a study of 15 cases
儿童多形性黄色星形细胞瘤15例组织学演变
- DOI:
10.1097/pat.0b013e328340bb98 - 发表时间:
2011 - 期刊:
- 影响因子:4.5
- 作者:
Xiangru Wu;P. Bandopadhayay;J. Ng;David M. Ashley;C. Chow - 通讯作者:
C. Chow
General anaesthesia or conscious sedation for painful procedures in childhood cancer: the family‘s perspective
全身麻醉或清醒镇静治疗儿童癌症的痛苦手术:家人的观点
- DOI:
10.1136/adc.88.3.253 - 发表时间:
2003 - 期刊:
- 影响因子:5.2
- 作者:
C. Crock;C. Olsson;R. Phillips;G. Chalkiadis;S. Sawyer;David M. Ashley;S. Camilleri;J. Carlin;P. Monagle - 通讯作者:
P. Monagle
Brain stem gliomas: Patterns of Care in Victoria from 1998–2000
- DOI:
10.1016/j.jocn.2007.04.008 - 发表时间:
2008-03-01 - 期刊:
- 影响因子:
- 作者:
Mark A. Rosenthal;David M. Ashley;Katharine J. Drummond;Michael Dally;Michael Murphy;Lawrence Cher;Vicky Thursfield;Graham G. Giles - 通讯作者:
Graham G. Giles
STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma
STING 激动剂 8803 重新编程免疫微环境并提高胶质母细胞瘤临床前模型的存活率
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:15.9
- 作者:
Hinda Najem;S. Lea;Shashwat Tripathi;Lisa Hurley;Chao;Ivana William;Moloud Sooreshjani;Michelle Bowie;Genevieve Hartley;Corey Dussold;Sebastian Pacheco;C. Dmello;Catalina Lee;Kathleen McCortney;Alicia Steffens;Jordain Walshon;Martina Ott;Jun Wei;Anantha L. Marisetty;I. Balyasnikova;R. Stupp;R. Lukas;Jian Hu;C. D. James;C. Horbinski;Maciej S. Lesniak;David M. Ashley;Waldemar Priebe;Leonidas C. Platanias;Michael A. Curran;Amy B. Heimberger - 通讯作者:
Amy B. Heimberger
David M. Ashley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David M. Ashley', 18)}}的其他基金
ATRX mutations, innate immune activation and therapeutic vulnerability in malignant gliomas
ATRX 突变、先天免疫激活和恶性胶质瘤的治疗脆弱性
- 批准号:
10375084 - 财政年份:2022
- 资助金额:
$ 34.28万 - 项目类别:
ATRX mutations, innate immune activation and therapeutic vulnerability in malignant gliomas
ATRX 突变、先天免疫激活和恶性胶质瘤的治疗脆弱性
- 批准号:
10666347 - 财政年份:2022
- 资助金额:
$ 34.28万 - 项目类别:
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
6-硫代-2-脱氧鸟苷:一种新型免疫原性端粒酶介导的胶质母细胞瘤疗法 - 杜克大学和 UTSW 合作
- 批准号:
10305565 - 财政年份:2021
- 资助金额:
$ 34.28万 - 项目类别:
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
GBM 中的 6-硫代-2-脱氧鸟苷:作用机制、功效和生物标志物鉴定的临床前评估
- 批准号:
10488242 - 财政年份:2021
- 资助金额:
$ 34.28万 - 项目类别:
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
6-硫代-2-脱氧鸟苷:一种新型免疫原性端粒酶介导的胶质母细胞瘤疗法 - 杜克大学和 UTSW 合作
- 批准号:
10488237 - 财政年份:2021
- 资助金额:
$ 34.28万 - 项目类别:
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
GBM 中的 6-硫代-2-脱氧鸟苷:作用机制、功效和生物标志物鉴定的临床前评估
- 批准号:
10305568 - 财政年份:2021
- 资助金额:
$ 34.28万 - 项目类别:
Is Low Tumor Mutational Burden Predictive of Response to Oncolytic Polio Virus Therapy in Recurrent Glioblastoma?
低肿瘤突变负荷是否可以预测复发性胶质母细胞瘤对溶瘤脊髓灰质炎病毒治疗的反应?
- 批准号:
9807277 - 财政年份:2019
- 资助金额:
$ 34.28万 - 项目类别:
相似国自然基金
基于腔光机械效应的石墨烯光纤加速度计研究
- 批准号:62305039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于自持相干放大的高精度微腔光力加速度计研究
- 批准号:52305621
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
位移、加速度双控式自复位支撑-高层钢框架结构的抗震设计方法及韧性评估研究
- 批准号:52308484
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高离心加速度行星排滚针轴承多场耦合特性与保持架断裂失效机理研究
- 批准号:52305047
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于偏心光纤包层光栅的矢量振动加速度传感技术研究
- 批准号:62305269
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Center of Research Translation on Osteoporosis Bone Anabolic Therapies
骨质疏松症骨合成代谢疗法研究转化中心
- 批准号:
10404412 - 财政年份:2023
- 资助金额:
$ 34.28万 - 项目类别:
Achieving Sustained Control of Inflammation to Prevent Post-Traumatic Osteoarthritis (PTOA)
实现炎症的持续控制以预防创伤后骨关节炎 (PTOA)
- 批准号:
10641225 - 财政年份:2023
- 资助金额:
$ 34.28万 - 项目类别:
The Illinois Precision Medicine Consortium (IPMC) All of Us Research Program Site
伊利诺伊州精准医学联盟 (IPMC) All of Us 研究计划网站
- 批准号:
10872859 - 财政年份:2023
- 资助金额:
$ 34.28万 - 项目类别:
NeuroMAP Phase II - Recruitment and Assessment Core
NeuroMAP 第二阶段 - 招募和评估核心
- 批准号:
10711136 - 财政年份:2023
- 资助金额:
$ 34.28万 - 项目类别:
Investigating the medical phenome of speech-language traits: risk, resilience, and opportunities for intervention
调查言语特征的医学现象:风险、恢复力和干预机会
- 批准号:
10799383 - 财政年份:2023
- 资助金额:
$ 34.28万 - 项目类别: